These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32757851)

  • 21. The Gyrolab™ immunoassay system: a platform for automated bioanalysis and rapid sample turnaround.
    Fraley KJ; Abberley L; Hottenstein CS; Ulicne JJ; Citerone DR; Szapacs ME
    Bioanalysis; 2013 Jul; 5(14):1765-74. PubMed ID: 23862708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The promise of cytokine antibody arrays in the drug discovery process.
    Huang RP; Yang W; Yang D; Flowers L; Horowitz IR; Cao X; Huang R
    Expert Opin Ther Targets; 2005 Jun; 9(3):601-15. PubMed ID: 15948677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Potential Use of Piglets as Human Pediatric Surrogate for Preclinical Pharmacokinetic and Pharmacodynamic Drug Testing.
    Gasthuys E; Vandecasteele T; De Bruyne P; Walle JV; De Backer P; Cornillie P; Devreese M; Croubels S
    Curr Pharm Des; 2016; 22(26):4069-85. PubMed ID: 26935702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin.
    Betts AM; Haddish-Berhane N; Tolsma J; Jasper P; King LE; Sun Y; Chakrapani S; Shor B; Boni J; Johnson TR
    AAPS J; 2016 Sep; 18(5):1101-1116. PubMed ID: 27198897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents.
    Goteti K; Garner CE; Utley L; Dai J; Ashwell S; Moustakas DT; Gönen M; Schwartz GK; Kern SE; Zabludoff S; Brassil PJ
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):245-54. PubMed ID: 19841922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ImmunoDB: a web based tool to analyze preclinical data.
    Lavieri R; Filaci G; Fenoglio D; Giacomini M
    Stud Health Technol Inform; 2014; 205():438-42. PubMed ID: 25160222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimens.
    Aljayyoussi G; Kay K; Ward SA; Biagini GA
    Malar J; 2016 Jul; 15(1):344. PubMed ID: 27388207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
    Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
    J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies: The generation game.
    Blow N
    Nature; 2007 Jun; 447(7145):741-4. PubMed ID: 17554312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing NBE PK/PD assays using the Gyrolab Affinity Software; conveniently within the bioanalyst's existing workflow.
    Myzithras M; Bigwarfe T; Waltz E; Li H; Ahlberg J; Rybina I; Low S; Kenny CH; Miglietta J; Kroe-Barrett R
    Bioanalysis; 2018 Mar; 10(6):397-406. PubMed ID: 29451404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.
    Findlay JW; Smith WC; Lee JW; Nordblom GD; Das I; DeSilva BS; Khan MN; Bowsher RR
    J Pharm Biomed Anal; 2000 Jan; 21(6):1249-73. PubMed ID: 10708409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample reduction strategies in discovery bioanalysis.
    Cai X; Zhang J; Shou WZ
    Bioanalysis; 2013 Jul; 5(13):1691-701. PubMed ID: 23822131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products.
    Shankar G; Devanarayan V; Amaravadi L; Barrett YC; Bowsher R; Finco-Kent D; Fiscella M; Gorovits B; Kirschner S; Moxness M; Parish T; Quarmby V; Smith H; Smith W; Zuckerman LA; Koren E
    J Pharm Biomed Anal; 2008 Dec; 48(5):1267-81. PubMed ID: 18993008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated analysis of routinely generated preclinical pharmacokinetic and pharmacodynamic data.
    Lindhardt E; Gennemark P
    J Bioinform Comput Biol; 2014 Jun; 12(3):1450010. PubMed ID: 24969748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Animal model pharmacokinetics and pharmacodynamics: a critical review.
    Andes D; Craig WA
    Int J Antimicrob Agents; 2002 Apr; 19(4):261-8. PubMed ID: 11978497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic/pharmacodynamic analysis in microbiology: a tool for the evaluation of the antimicrobial treatment].
    Canut Blasco A; Aguilar Alfaro L; Cobo Reinoso J; Giménez Mestre MJ; Rodríguez-Gascón A
    Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):48-57. PubMed ID: 23850188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference in immunoassays to support therapeutic antibody development in preclinical and clinical studies.
    Schwickart M; Vainshtein I; Lee R; Schneider A; Liang M
    Bioanalysis; 2014; 6(14):1939-51. PubMed ID: 24806787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A powerful antiradiation compound revealed by a new high-throughput screening method.
    Meunier S; Desage-El Murr M; Nowaczyk S; Le Gall T; Pin S; Renault JP; Boquet D; Créminon C; Saint-Aman E; Valleix A; Taran F; Mioskowski C
    Chembiochem; 2004 Jun; 5(6):832-40. PubMed ID: 15174167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical pharmacokinetic/pharmacodynamic models of gefitinib and the design of equivalent dosing regimens in EGFR wild-type and mutant tumor models.
    Wang S; Guo P; Wang X; Zhou Q; Gallo JM
    Mol Cancer Ther; 2008 Feb; 7(2):407-17. PubMed ID: 18281523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical assessment of novel BRAF inhibitors: integrating pharmacokinetic-pharmacodynamic modelling in the drug discovery process.
    Choo EF; Alicke B; Boggs J; Dinkel V; Gould S; Grina J; West K; Menghrajani K; Ran Y; Rudolph J; Wenglowsky S
    Xenobiotica; 2011 Dec; 41(12):1076-87. PubMed ID: 21864203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.